HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Age defining immune effector cell associated neurotoxicity syndromes in aggressive large B cell lymphoma patients treated with axicabtagene ciloleucel.

AuthorsKitsada Wudhikarn, Radhika Bansal, Arushi Khurana, Matthew A Hathcock, Sherri A Braksick, N Nora Bennani, Jonas Paludo, Jose C Villasboas, Yucai Wang, Patrick B Johnston, Stephen M Ansell, Yi Lin
JournalAmerican journal of hematology (Am J Hematol) Vol. 96 Issue 11 Pg. E427-E430 (11 01 2021) ISSN: 1096-8652 [Electronic] United States
PMID34424554 (Publication Type: Letter)
Chemical References
  • Antineoplastic Agents, Immunological
  • Biological Products
  • axicabtagene ciloleucel
Topics
  • Adult
  • Age Factors
  • Aged
  • Agraphia (etiology)
  • Antineoplastic Agents, Immunological (adverse effects, therapeutic use)
  • Aphasia (etiology)
  • Biological Products (adverse effects, therapeutic use)
  • Confusion (etiology)
  • Humans
  • Immunotherapy, Adoptive (adverse effects)
  • Lymphoma, Large B-Cell, Diffuse (therapy)
  • Middle Aged
  • Neurotoxicity Syndromes (etiology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: